Module 12_Dementia: Causes,
Reading: Chapter 12, pages 487–537. No reference needed. No Cover Page.
Module 12 Weekly Note. Address each heading in the Chapter 12 outline.
Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine
Dementia: Diagnosis and Causes — p. 487
What Is Dementia? — p. 487
What Is Mild Cognitive Impairment (MCI)? — p. 487
Four Major Causes of Dementia — p. 488
Pursuit of Disease-Modifying Therapies by Targeting Aβ in Alzheimer Disease — p. 496
The Amyloid Cascade Hypothesis — p. 496
Current Status of the Amyloid Cascade Hypothesis and Treatments Targeting Aβ — p. 499
Diagnosing Alzheimer Disease Before It Is Too Late — p. 499
Presymptomatic Stage 1 — p. 499
MCI Stage 2 — p. 500
Dementia Stage 3 — p. 502
Overview of Symptomatic Treatments for Dementia — p. 503
Targeting Acetylcholine for the Symptomatic Treatment of Memory and Cognition in Alzheimer Disease — p. 505
Acetylcholine: Synthesis, Metabolism, Receptors, and Pathways — p. 505
Symptomatic Treatment of Memory and Cognition in Alzheimer Disease by Inhibiting Acetylcholinesterase — p. 509
Targeting Glutamate for the Symptomatic Treatment of Memory and Cognition in Alzheimer Disease — p. 515
Memantine — p. 516
Targeting the Behavioral Symptoms of Dementia — p. 521
Defining Agitation and Psychosis in Alzheimer Disease — p. 521
Pharmacological Treatment of Psychosis and Agitation in Dementia — p. 523
Targeting Serotonin for the Symptomatic Treatment of Dementia-Related Psychosis — p. 524
Neuronal Networks of Agitation in Alzheimer Disease — p. 528
Targeting Multimodal Neurotransmitters (Norepinephrine, Serotonin, and Dopamine) for the Symptomatic Treatment of Agitation in Alzheimer Disease — p. 530
Targeting Glutamate for the Symptomatic Treatment of Agitation in Alzheimer Disease — p. 533
Treating Depression in Dementia — p. 534
Pseudobulbar Affect (Pathological Laughing and Crying) — p. 535
Apathy — p. 536
Other Treatments for the Behavioral Symptoms of Dementia — p. 537
Summary — p. 537